BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2859842)

  • 1. Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I.
    Gogel HK; Buckman MT; Cadieux D; McCarthy DM
    Arch Intern Med; 1985 May; 145(5):855-9. PubMed ID: 2859842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of parathyroidectomy or calcium channel blockade on serum gastrin concentration and gastric acid secretion in a patient with hyperparathyroidism and Zollinger-Ellison syndrome.
    Stevens MH; Thirlby RC; Richardson CT
    Surgery; 1987 Jan; 101(1):108-13. PubMed ID: 3798319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum gastrin and its response to secretin in hyperparathyroid patients.
    Selking O; Johansson H; Lundqvist G
    Acta Chir Scand; 1981; 147(8):649-55. PubMed ID: 7344385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.
    Norton JA; Cornelius MJ; Doppman JL; Maton PN; Gardner JD; Jensen RT
    Surgery; 1987 Dec; 102(6):958-66. PubMed ID: 2891201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia, type I (MEN I).
    Eberle F; GrĂ¼n R
    Ergeb Inn Med Kinderheilkd; 1981; 46():76-149. PubMed ID: 6262073
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum gastrin level is increased by chronic hypercalcemia of parathyroid or nonparathyroid origin.
    Zaniewski M; Jordan PH; Yip B; Thornby JI; Mallette LE
    Arch Intern Med; 1986 Mar; 146(3):478-82. PubMed ID: 2869739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.
    Betts JB; O'Malley BP; Rosenthal FD
    Q J Med; 1980; 49(193):69-76. PubMed ID: 6107954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple endocrine neoplasms associated with Zollinger-Ellison syndrome and hyperparathyroidism].
    Tellaroli JC; Charleux H; Semin AM; Parrot B; Fasano JJ; Cain P
    Ann Gastroenterol Hepatol (Paris); 1984; 20(4):199-201. PubMed ID: 6152141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does hyperparathyroidism cause hypergastrinemia?
    Wilson SD; Singh RB; Kalkhoff RK
    Surgery; 1976 Aug; 80(2):231-7. PubMed ID: 941095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zollinger-Ellison syndrome associated with parathyroid adenomas and ectopic gastric tissue in the lower esophageal mucosa.
    Nakayasu A; Dowell AJ; Reynolds C; Stordy SN; Cleator IG
    Can J Surg; 1979 Jan; 22(1):71-8. PubMed ID: 445242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological diagnosis of Zollinger-Ellison syndrome in the context of a polyendocrine adenomatosis].
    Bonfils S; Bernades P; Letonturier P
    Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2027-31. PubMed ID: 241055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome.
    Isenberg JI; Walsh JH; Passaro E; Moore EW; Grossman MI
    Gastroenterology; 1972 Apr; 62(4):626-31. PubMed ID: 5020875
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
    Mignon M
    Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Zollinger-Ellison syndrome produced by gastrinoma in the duodenum accompanied with multiple endocrine neoplasia type 1.
    Yazawa K; Kuroda T; Watanabe H; Shimozawa N; Nakata S; Fujimori Y; Koide N; Koike S; Kajikawa S; Adachi W; Amano J
    Hepatogastroenterology; 1999; 46(25):257-60. PubMed ID: 10228803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1--presenting with impotence.
    Lye WC; Lee KO; Tay HH
    Singapore Med J; 1990 Jun; 31(3):277-9. PubMed ID: 1975461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
    Wada M; Komoto I; Doi R; Imamura M
    World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
    Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
    Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view.
    Pellicano R; De Angelis C; Resegotti A; Rizzetto M
    Panminerva Med; 2006 Mar; 48(1):33-40. PubMed ID: 16633330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism and hypergastrinemia revisited.
    Primrose JN; Joffe SN
    Surgery; 1984 Dec; 96(6):1144-50. PubMed ID: 6505967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.